PMDA — authorised 26 September 2022
- Marketing authorisation holder: UCB JAPAN CO., LTD.
- Status: approved
🇯🇵 Fintepla in Japan
PMDA authorised Fintepla on 26 September 2022
Marketing authorisation
Fintepla in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Japan
Frequently asked questions
Is Fintepla approved in Japan?
Yes. PMDA authorised it on 26 September 2022.
Who is the marketing authorisation holder for Fintepla in Japan?
UCB JAPAN CO., LTD. holds the Japanese marketing authorisation.